These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38293707)

  • 1. Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
    Dong L; Feng M; Kuczler MD; Horie K; Kim CJ; Ma Z; Lombardo K; Lyons H; Amend SR; Kates M; Bivalacqua TJ; McConkey D; Xue W; Choi W; Pienta KJ
    J Extracell Vesicles; 2024 Feb; 13(2):e12402. PubMed ID: 38293707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens.
    Koll FJ; Döring C; Olah C; Szarvas T; Köllermann J; Hoeh B; Chun FK; Reis H; Wild PJ
    BMC Cancer; 2023 Jun; 23(1):504. PubMed ID: 37270477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients.
    Jordaens S; Oeyen E; Willems H; Ameye F; De Wachter S; Pauwels P; Mertens I
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study.
    Xiao Y; Ju L; Qian K; Jin W; Wang G; Zhao Y; Jiang W; Liu N; Wu K; Peng M; Cao R; Li S; Shi H; Gong Y; Zheng H; Liu T; Luo Y; Ma H; Chang L; Li G; Cao X; Tian Y; Xu Z; Yang Z; Shan L; Guo Z; Yao D; Zhou X; Chen X; Guo Z; Liu D; Xu S; Ji C; Yu F; Hong X; Luo J; Cao H; Zhang Y; Wang X
    Clin Transl Med; 2022 Aug; 12(8):e1008. PubMed ID: 35968916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype profile by flow cytometry reveals different subtypes of extracellular vesicles in porcine seminal plasma.
    Barranco I; Alvarez-Barrientos A; Parra A; Martínez-Díaz P; Lucas X; Roca J
    Cell Commun Signal; 2024 Jan; 22(1):63. PubMed ID: 38263049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference.
    Bardi GT; Al-Rayan N; Richie JL; Yaddanapudi K; Hood JL
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
    Oeyen E; Hoekx L; De Wachter S; Baldewijns M; Ameye F; Mertens I
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases.
    Sjödahl G; Eriksson P; Lövgren K; Marzouka NA; Bernardo C; Nordentoft I; Dyrskjøt L; Liedberg F; Höglund M
    Mod Pathol; 2018 Dec; 31(12):1869-1881. PubMed ID: 29967424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Variability of Small Extracellular Vesicles Derived from Human Liver Cancer Tissues and Cultured from the Tissue Explants Based on a Simple Enrichment Method.
    Chen J; Jiao Z; Mo J; Huang D; Li Z; Zhang W; Yang T; Zhao M; Xie F; Hu D; Wang X; Yi X; Jiang Y; Zhong T
    Stem Cell Rev Rep; 2022 Mar; 18(3):1067-1077. PubMed ID: 34550537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Approach for Prostate Cancer Diagnosis by miRNA Profiling of Prostate-Derived Plasma Small Extracellular Vesicles.
    Zabegina L; Nazarova I; Nikiforova N; Slyusarenko M; Sidina E; Knyazeva M; Tsyrlina E; Novikov S; Reva S; Malek A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer.
    Hagey DW; Kordes M; Görgens A; Mowoe MO; Nordin JZ; Moro CF; Löhr JM; El Andaloussi S
    J Extracell Vesicles; 2021 Oct; 10(12):e12142. PubMed ID: 34595842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Seiler R; Ashab HAD; Erho N; van Rhijn BWG; Winters B; Douglas J; Van Kessel KE; Fransen van de Putte EE; Sommerlad M; Wang NQ; Choeurng V; Gibb EA; Palmer-Aronsten B; Lam LL; Buerki C; Davicioni E; Sjödahl G; Kardos J; Hoadley KA; Lerner SP; McConkey DJ; Choi W; Kim WY; Kiss B; Thalmann GN; Todenhöfer T; Crabb SJ; North S; Zwarthoff EC; Boormans JL; Wright J; Dall'Era M; van der Heijden MS; Black PC
    Eur Urol; 2017 Oct; 72(4):544-554. PubMed ID: 28390739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
    Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of small extracellular vesicles in lung cancer: Molecular pathology, mechanisms, diagnostics, and therapeutics.
    Liu Y; Xia Y; Smollar J; Mao W; Wan Y
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188539. PubMed ID: 33892051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer.
    Sirab N; Drubay D; Maillé P; Popova T; Ngo C; Gentien D; Moktefi A; Soyeux-Porte P; Pelletier R; Reyes C; Henry E; Pouessel D; Vordos D; Lebret T; de Reyniès A; Paoletti X; Radvanyi F; Allory Y
    J Pathol; 2022 Jan; 256(1):108-118. PubMed ID: 34611919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study.
    Zhang W; Wang L; Li D; Campbell DH; Walsh BJ; Packer NH; Dong Q; Wang E; Wang Y
    Anal Methods; 2022 Jun; 14(23):2255-2265. PubMed ID: 35612592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.